Washington Post: We have the technology to customize our babies. It needs regulation.
Editorial Board

“When Chinese scientist He Jiankui announced last November his experiments making heritable genetic changes in human embryos followed by live births of twins, alarms went off. What shocked many scientists and others was how Mr. He used new technology for gene editing without serious oversight or transparency, amid grave questions about the medical rationale and potential future damage. One good thing came out of this: Mr. He spurred a more deliberate, international effort to answer the hard questions. Now that effort must lead to stricter regulation. … Fortunately, the right organizations are now in motion. The U.S. National Academies and the British Royal Society have launched an international commission. The World Health Organization has created an advisory committee, too. We hope these efforts will find a consensus that can be accepted and enforced by the widest circle possible. The goal must be a framework that will enable genuine scientific advancement but avoid reckless fiddling with the source code of life. It is a tall order — and an urgent need” (5/21).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.